Do urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer?

Simsekoglu, Muhammed; Kaleler, Islim; ÖNAL, Bülent; DEMİRDAĞ, Çetin; ÇİTGEZ, Sinharib; Uslu, Fatma; Erozenci, Ahmet; Talat, Zübeyr

doi:10.1111/ijcp.13959

Do urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer?

Copy For Citation

Simsekoglu M. F. , Kaleler I., ÖNAL B., DEMİRDAĞ Ç., ÇİTGEZ S., Uslu E. , ...More

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume:
Publication Date: 2021
Doi Number: 10.1111/ijcp.13959
Title of Journal : INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Abstract

Background Mast cells play a critical role in cancer-associated immunity. We aimed to determine the predictive value of urinary mast cell mediators in patients with non-muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG) immunotherapy.